Results 221 to 230 of about 107,677 (297)

The Treatment of Cosmetic Defects-II.

, 1893

openalex   +1 more source

The Effect of Religiosity, Halal Knowledge, Subjective Norm on Purchase Intention of Halal Cosmetic Mediated by Attitude Among Millennials in West Sumatera

Kuntum Khaira Ummah, Verinita Verinita, Ma’ruf Ma’ruf   +2 more
openalex   +2 more sources

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

Benzene in cosmetic products: Non cancer and cancer risk assessment. [PDF]

Toxicol Rep
Gautam A, Cressey PJ.
europepmc   +1 more source

On the possibility of using seaweeds as raw materials for producing cosmetics and cosmeceuticals (Review)

Pavel Yavich, M. G. Kakhetelidze, Bella Kikalishvili   +2 more
openalex   +2 more sources

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Evaluating the Efficacy of Soothing Agents in Mitigating 0.1% Retinol-Induced Skin Irritation: A Patch Test. [PDF]

J Cosmet Dermatol
Ying Y, Fang Y, Chenlan X, Lin S, Jiefang H, Yanan L, Peiwen S.   +6 more
europepmc   +1 more source

CONSUMER HABITS AND PRACTICES FOR COSMETICS: A STATISTICAL APPROACH

R.V. Bucur, Sorina Geanina Stănescu, Cristiana Rădulescu, Andreea Laura Banica, Raluca Maria Ştirbescu   +4 more
openalex   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source

A Case-Control Study Exploring the Association Between Cosmetic Use and Acne Risk: Implications for Prevention and Clinical Practice. [PDF]

Clin Cosmet Investig Dermatol
Choi K, Liu H, Zhu Y, Jiang Z, Lu S.
europepmc   +1 more source